- Home
- AGMB vs HSTM Comparison
AGMB vs HSTM Comparison
Compare AGMB & HSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AGMB | HSTM |
|---|---|---|
| Founded | 2017 | 1990 |
| Country | Belgium | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 677.9M | 642.6M |
| IPO Year | N/A | 1999 |
Fundamental Metrics
Financial Performance| Metric | AGMB | HSTM |
|---|---|---|
| Price | $11.86 | $21.26 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 1 |
| Target Price | ★ $32.00 | $28.00 |
| AVG Volume (30 Days) | 137.3K | ★ 154.5K |
| Earning Date | 04-23-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 0.66% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.61 |
| Revenue | N/A | ★ $304,064,000.00 |
| Revenue This Year | N/A | $9.45 |
| Revenue Next Year | $17.86 | $5.12 |
| P/E Ratio | ★ N/A | $34.15 |
| Revenue Growth | N/A | ★ 4.26 |
| 52 Week Low | $9.00 | $19.50 |
| 52 Week High | $17.45 | $29.62 |
Technical Indicators
Market Signals| Indicator | AGMB | HSTM |
|---|---|---|
| Relative Strength Index (RSI) | 54.88 | 52.87 |
| Support Level | $10.30 | $21.19 |
| Resistance Level | $12.21 | $21.72 |
| Average True Range (ATR) | 0.84 | 0.60 |
| MACD | 0.21 | -0.00 |
| Stochastic Oscillator | 68.15 | 58.41 |
Price Performance
Historical ComparisonAbout AGMB AgomAb Therapeutics NV American Depositary Shares
AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need. Its product candidates are designed to target established pathways and utilize validated modalities, with a focus on addressing limitations associated with prior treatment approaches. The company's pipeline includes small molecule and antibody product candidates aimed at targets associated with fibrotic diseases. Key candidates include Ontunisertib (AGMB-129) and AGMB-447.
About HSTM HealthStream Inc.
HealthStream Inc provides workforce and provider solutions for healthcare organizations. Its reportable segments include Workforce Solutions and Provider Solutions. Workforce development solutions consist of SaaS, subscription-based products that are used by healthcare organizations. Its Provider Solutions products offer healthcare organizations software applications for administering and tracking provider credentialing, privileging, call center and enrollment activities. The company generates a majority of its revenue from Subscription Services.